Loss of NK cell cytotoxicity to pertussis vaccination has previously been demonstrated to correlate with increased frequency of CD57+ NK cells (48); thus, expansion of the CD57+ NK cell population in CMV-seropositive donors may affect total NK cell activation to IL-2 secretion. The gene discussed is B3GAT1; the disease is pertussis.